Showing results (101-110 of 8,885) with videos related to
Sort By:
Pageof 889
European Urology|May 28, 2003
Functional outcome after pyeloplasty in children: impact of the cause of obstruction and of the mode of presentationA Calisti, M L Perrotta, L Oriolo, et al.European Urology|January 1, 1992
Digital rectal examination, imaging, and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinomaP Hammerer, H Huland, A SparenbergEuropean Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay PrasadEuropean Urology|November 16, 2021
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular SubtypesGottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al.European Urology|December 5, 2021
Inherited TP53 Variants and Risk of Prostate CancerKara N Maxwell, Heather H Cheng, Jacquelyn Powers, et al.European Urology|November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial CarcinomaRichard Cathomas, Anja Lorch, Harman M Bruins, et al.European Urology|February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate CancerVincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.European Urology|March 13, 2019
Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate CancerDominic H Moon, Ram S Basak, Deborah S Usinger, et al.European Urology|November 12, 2018
A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder CancerAndrew Goodspeed, Annie Jean, James C CostelloEuropean Urology|January 1, 1986
Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumorB Llopis, J Gallego, J A Mompó, et al.Pageof 889